লোডিং...
Signature for Long-Term Vaccine-Mediated Control of a Simian and Human Immunodeficiency Virus 89.6P Challenge: Stable Low-Breadth and Low-Frequency T-Cell Response Capable of Coproducing Gamma Interferon and Interleukin-2
In 2001, we reported 20 weeks of control of challenge with the virulent 89.6P chimera of simian and human immunodeficiency viruses (SHIV-89.6P) by a Gag-Pol-Env vaccine consisting of DNA priming and modified vaccinia virus Ankara boosting. Here we report that 22 out of 23 of these animals successful...
সংরক্ষণ করুন:
প্রধান লেখক: | , , , , , , , , |
---|---|
বিন্যাস: | Artigo |
ভাষা: | Inglês |
প্রকাশিত: |
American Society for Microbiology
2005
|
বিষয়গুলি: | |
অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1075739/ https://ncbi.nlm.nih.gov/pubmed/15731219 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.79.6.3243-3253.2005 |
ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|